Combination Therapy with Apremilast and Biologics for Psoriasis: A Systematic Review

Keyphrases

• Combination Therapy 100%
• Psoriasis 100%
• Apremilast 100%
• Adverse Events 42%
• Literature Search 28%
• Clinical Response 14%
• Embase 14%
• Hospitalization 14%
• Biological Treatment 14%
• Europe 14%
• Cochrane Library 14%
• PubMed 14%
• Monotherapy 14%
• Combined Treatment 14%
• Inclusion Criteria 14%
• Patient Selection 14%
• Lack of Efficacy 14%
• Observation Period 14%
• Combination Treatment 14%
• MEDLINE 14%
• Weight Loss 14%
• Efficacy Data 14%
• Gastrointestinal 14%
• Web of Science 14%
• Serious Adverse Events 14%
• North America 14%
• Asia 14%
• Clinical Investigation 14%
• Biological Agents 14%
• Small Molecule Drugs 14%
• Concomitant Treatment 14%
• Palmoplantar Pustulosis 14%
• Plaque Psoriasis 14%
• Clinical Subtypes 14%
• Geographical Origin 14%
• Biologic Therapy 14%
• Add-on Treatment 14%
• Pustular Psoriasis 14%

Medicine and Dentistry

• Systematic Review 100%
• Combination Therapy 100%
• Psoriasis 100%
• Apremilast 100%
• Biological Product 71%
• Adverse Event 57%
• Retrospective Study 28%
• Cohort Analysis 14%
• Monotherapy 14%
• Biological Therapy 14%
• Pustulosis Palmaris Et Plantaris 14%
• Psoriasis Vulgaris 14%
• Pustular Psoriasis 14%

Pharmacology, Toxicology and Pharmaceutical Science

• Combination Therapy 100%
• Psoriasis 100%
• Apremilast 100%
• Biological Product 71%
• Adverse Event 57%
• Retrospective Study 28%
• Cohort Study 14%
• Monotherapy 14%
• Psoriasis Vulgaris 14%
• Pustulosis palmoplantaris 14%
• Pustular Psoriasis 14%